CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndCash from financing (Million JPY)YoY (%)
Jun 30, 20251,749+13.69%
Jun 30, 20241,538-32.31%
Jun 30, 20232,273+703.75%
Jun 30, 2022283-61.20%
Jun 30, 2021729-19.17%
Jun 30, 2020902+31.98%
Jun 30, 2019683+8958.50%
Jun 30, 20188-98.02%
Jun 30, 2017381+1.51%
Jun 30, 2016375-56.18%
Jun 30, 2015856+680.75%
Jun 30, 2014110
AI Chat